Pricing and reimbursement

Generally, from the patients’ perspective, the market access of an outpatient medicinal product requires that a product is reimbursed through health insurance. Optimally, the new drug will be available to patients in need as quickly and extensively as possible and at a competitive price. The price and reimbursement application process plays an important role in this.

To do this, we provide assistance to our clients at all stages of the price and reimbursement application process. The service is tailored to meet our customer’s needs. We provide assistance to help you through the whole application process, from health economic evaluation and RWE studies to smaller consultation assistance at different stages of application processes.

 

Our comprehensive and customized pricing and reimbursement services include: 

  • Providing strategic and tactical counseling in the different phases of the pricing and reimbursement application process
  • Preparing and compiling basic and special reimbursement applications for medicinal products containing a new active ingredient, applications for renewal and extension, and applications concerning a new strength, package size and pharmaceutical form
    • This also includes the health economic studies required for the application as well as any needed RWE studies
  • Providing expert assistance and advice on risk-sharing agreements and contractual arrangements for conditional reimbursement

 

For more information on the price and reimbursement process read our article Market access, pricing and reimbursement of medicines in Finland.

 

We are more than happy to tell you more!

Ritva Suominen
Ritva Suominen
Sr. Market Access Manager
P&R Lead

Contact us

Our Pricing and Reimbursement Experts:

Ritva Suominen
Ritva Suominen
Sr. Market Access Manager
P&R Lead
Ritva Suominen

Ritva Suominen

Sr. Market Access Manager
P&R Lead
M.Sc. (Pharm.)

LinkedIn

Ritva joined Medaffcon’s team in March 2018. Before this, she had worked for almost six years at Farenta in corresponding tasks, providing pharmaceutical companies with strategic consultation and expert assistance related to Market Access functions. In addition, Ritva holds more than 20 years of experience in the pharmaceutical industry, where she has worked as a Market Access Manager at Sanofi (12 years), as a Regulatory Affairs Manager at Bayer and as a Researcher in Pharmaceutical Product Development at Orion.

In the pharmaceutical industry, Ritva is interested in Market Access issues particularly due to their diversity and societal impact. “Market Access is a great observational spot to view the development of new innovative medicinal treatment, aiming to improve patients’ treatment in its entirety. I consider it important to increase cooperation between different actors in the pharmaceutical industry and to find such new solution models that make effective treatment optimally available for patients without raising society’s costs unreasonably“.


Jarmo Hahl
Jarmo Hahl
Managing Director
Jarmo Hahl

Jarmo Hahl

Managing Director
M.Sc. (Economics)

LinkedIn

Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.

Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.

“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.


Tatu Sainio
Tatu Sainio
Sr. Health Economist
Access & HE Lead
Tatu Sainio

Tatu Sainio

Sr. Health Economist
Access & HE Lead
M.Sc. (Economics & Health Economics)

LinkedIn

Tatu joined Medaffcon in the fall of 2016. Tatu holds two master’s degrees, majoring in Marketing and Health Economics. Before joining Medaffcon, he worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager. At Medaffcon, Tatu works mainly with health technology assessments and is the access & health economics team lead. Through his educational and professional background, Tatu has a wide range of expertise in the pharmaceutical industry and understands the needs of each function.

Tatu’s strength is his comprehensive understanding of the pharmaceutical industry and healthcare environment. Tatu is particularly interested in the possibility to turn data into understandable information to support healthcare decision-making.

“I love the hype around the utilization of real-world effectiveness and cost-effectiveness data. Now we need steps to include the data as a systematic part of the decision-making process, which allows the optimal allocation of resources”.


Heini Honkanen
HEMAR Manager

Heini Honkanen

HEMAR Manager
M.Sc. (Health Economics)

LinkedIn

Heini joined Medaffcon’s Market Access team in May 2018. She has graduated in Health Economics from the University of Eastern Finland, and her master’s thesis discusses risk-sharing agreements in the pharmaceutical market.

Heini is interested in the changes occurring in the pharmaceutical and healthcare industries as well as in the possibilities of Health Economics in assessing the methods and economic resources in the field. Heini’s assets include her state-of-the-art theoretical knowledge in the field of Health Economics, combined with practice- and patient-oriented thinking.


Emmi Puumalainen - Market Access Specialist - Medaffcon Oy
Emmi Puumalainen
Market Access Specialist
Emmi Puumalainen - Market Access Specialist - Medaffcon Oy

Emmi Puumalainen

Market Access Specialist
M.Sc. (Pharm.)

LinkedIn

Emmi joined Medaffcon’s P&R team in December 2020.  Previously Emmi worked at the University of Helsinki in different teaching positions while working on her doctoral dissertation. Emmi has wide-ranging experience from working at pharmacies and different pharmacy organizations. At Medaffcon Emmi hopes to immerse herself to the price and reimbursement processes and adapt to the ever-changing practices in the field. Market Access is interesting to Emmi because she has witnessed in her pharmacy work, the impact that access to new treatments has in the patients’ lives.

“It’s great to be able to help in bringing new treatments to the market and ensuring the best possible patient access to them. In these functions there’s always new things to learn and to get excited about.”